
Adamis Pharmaceuticals (NASDAQ:ADMP) brought in sales totaling $1.16 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 18.01%, resulting in a loss of $10.35 million. Adamis Pharmaceuticals collected $1.16 million in revenue during Q4, but reported earnings showed a $8.77 million loss.